These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7816208)

  • 1. Distribution of cholecystokinin receptors in the bovine brain: a quantitative autoradiographic study.
    Morency MA; Quirion R; Mishra RK
    Neuroscience; 1994 Sep; 62(1):307-16. PubMed ID: 7816208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of [125I]Bolton Hunter CCK8 and [3H]MK-329 (devazepide) binding to CCK receptors in the substantia nigra/VTA complex and its forebrain projection areas following MPTP-induced hemi-parkinsonism in the monkey.
    Graham WC; Hill DR; Woodruff GN; Sambrook MA; Crossman AR
    Neurosci Lett; 1991 Sep; 131(1):129-34. PubMed ID: 1791971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the distribution of cholecystokinin receptor binding sites in the human brain: an autoradiographic study.
    Dietl MM; Probst A; Palacios JM
    Synapse; 1987; 1(2):169-83. PubMed ID: 3505367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125I-Bolton Hunter CCK-8 and 3H-MK-329.
    Hill DR; Shaw TM; Graham W; Woodruff GN
    J Neurosci; 1990 Apr; 10(4):1070-81. PubMed ID: 2329368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative autoradiographic localization of cholecystokinin receptors in rat and guinea pig brain using 125I-Bolton-Hunter-CCK8.
    Niehoff DL
    Peptides; 1989; 10(2):265-74. PubMed ID: 2755869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
    Corp ES; McQuade J; Moran TH; Smith GP
    Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260.
    Hill DR; Woodruff GN
    Brain Res; 1990 Sep; 526(2):276-83. PubMed ID: 2257485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of [3H]cholecystokinin octapeptide binding sites in the hippocampal region of the rat brain as shown by in vitro receptor autoradiography.
    Köhler C; Hallman H; Radesäter AC
    Neuroscience; 1987 Jun; 21(3):857-67. PubMed ID: 3627438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of 125I-Bolton-Hunter labelled cholecystokinin binding in human brain.
    Cross AJ; Slater P; Skan W
    Neuropeptides; 1988; 11(2):73-6. PubMed ID: 3368039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional distribution of cholecystokinin receptors in macaque medial temporal lobe determined by in vitro receptor autoradiography.
    Kritzer MF; Innis RB; Goldman-Rakic PS
    J Comp Neurol; 1988 Oct; 276(2):219-30. PubMed ID: 3220981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of cholecystokinin binding sites in canine brain using quantitative autoradiography.
    Morency MA; Quirion R; Nair NP; Mishra RK
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):291-6. PubMed ID: 1871331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative autoradiographic distribution of [125I]Bolton-Hunter neuropeptide Y receptor binding sites in rat brain. Comparison with [125I]peptide YY receptor sites.
    Martel JC; Fournier A; St Pierre S; Quirion R
    Neuroscience; 1990; 36(1):255-83. PubMed ID: 2170863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
    Vasar E; Stephenson JD; Meldrum BS
    Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional distribution of cholecystokinin binding sites in macaque basal ganglia determined by in vitro receptor autoradiography.
    Kritzer MF; Innis RB; Goldman-Rakic PS
    Neuroscience; 1990; 38(1):81-92. PubMed ID: 2255400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The distribution of cholecystokinin receptors in the vertebrate brain: species differences studied by receptor autoradiography.
    Dietl MM; Palacios JM
    J Chem Neuroanat; 1989; 2(3):149-61. PubMed ID: 2789732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin receptors in cells of the immune system.
    Lignon MF; Bernad N; Martinez J
    Ann N Y Acad Sci; 1994 Mar; 713():334-7. PubMed ID: 8185180
    [No Abstract]   [Full Text] [Related]  

  • 18. Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,260, in rat brain.
    Ge J; Long SK; Kilpatrick IC
    Eur J Pharmacol; 1998 Mar; 345(2):163-70. PubMed ID: 9600632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin receptors in brain revisited.
    Palacios JM
    Brain Res; 2016 Aug; 1645():46-9. PubMed ID: 26740406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor.
    Pu SF; Zhuang HX; Han JS
    Brain Res; 1994 Sep; 657(1-2):159-64. PubMed ID: 7820614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.